Physician profile
Timothy P Connelly
NPI 1467616748
$49,860.98
in general payments reported to CMS, 2019-2025
17 companies · $26K in 2025
The $26K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $324 · 2020: $102 · 2021: $112 · 2023: $5,016 · 2024: $18K · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Consulting Fee: $13K · Travel and Lodging: $4,275 · Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,360.99 |
| Consulting Fee | $13,228.00 |
| Travel and Lodging | $4,274.62 |
| Food and Beverage | $458.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $49,245.59 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $143.91 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $75.05 | 2020-2024 | Dificid, Pifeltro, Delstrigo |
| E.R. Squibb & Sons, L.L.C. | $59.15 | 2019-2024 | Eliquis |
| Lilly USA, LLC | $52.81 | 2021-2025 | Mounjaro, Zepbound |
| Janssen Pharmaceuticals, INC | $40.94 | 2019-2020 | |
| Novo Nordisk INC | $34.09 | 2019-2020 | |
| Eisai INC. | $29.34 | 2025 | |
| Astellas Pharma US INC | $23.42 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.89 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $21.80 | 2019 | |
| Abbott Laboratories | $21.53 | 2023 | Freestyle Libre 3 |
| Boston Scientific Corporation | $21.16 | 2025 | Watchman Flx |
| Exact Sciences Corporation | $20.57 | 2025 | The Cologuard Plus Collection Kit |
| Organon LLC | $19.37 | 2025 | Nexplanon |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $15.76 | 2019 | |
| Horizon Therapeutics Plc | $14.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Connelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.